Molecular Staging and Metastatic State Prediction
Accurately predict tumor progression rate and metastasis analysis
Tumor Molecular Profiling & Monitoring
Prediction of Metastasis Occurrence
There are many scenarios in which metastasis is a lethal outcome of cancer. Estimates suggest that metastasis is responsible for about 90% of cancer deaths. By using AI technology and genetic markers in blood plasma, we can assess whether a case is curable and determine the necessary steps to ensure a patient’s survival. This screening service works similarly to our diagnostic and staging processes but uses a new algorithm that targets biomarkers specific to the metastasis process. This screening enables us to determine how fast a tumor is growing, how much it has grown in the past, and how fast it will continue to grow based on the data presented. The ability to diagnose metastasis presents amazing potential for increasing the survival rate of patients. As more data is provided over time, we can decrease the time it takes to diagnose the progression of metastatic tumors, giving patients more time to plan a successful treatment plan.
Evaluate your patient’s overall condition to estimate the probability of metastasis occurrence and identify the target tissue.
Prediction of Metastasis Occurrence and Probability
Using an AI algorithm and gene expression profiles, you can predict the probability of metastasis occurrence.
The aim of this solution is to provide information about the overall invasiveness of cancer. It evaluates your patient’s condition to estimate the probability of metastasis occurrence and the targeted tissue. Whether metastasis has occurred or not, this service provides information about the expression levels of metastatic-related genes, giving you an overview of the different metastatic steps of your patient. Additionally, the exact molecular staging is an excellent feature of this service that can accurately classify your patient based on their gene expression profile. You can use this package to plan chemotherapy, estimate future surgery options, monitor the invasiveness of cancer in your patient, identify which metastasis-related processes are progressing inside the tumor, and even prevent metastasis before it occurs.
Prediction of Target Tissue of Metastasis
The target of cancer metastasis is a crucial factor in patient survival. The combination of metastasis probability and its target can provide an opportunity to quickly screen the target tissue, trace, and halt metastasis at its early stages.
A profile of essential differentially expressed genes in metastasis with visualizations
There are some very important genes whose deregulation critically impacts the occurrence of metastasis. These genes are mostly involved in metastasis-related pathways, such as angiogenesis, epithelial-mesenchymal transition, and cell migration. Here, we will provide information on the overexpression or downregulation of these genes, along with detailed statistical information. Then, we will give you details of the role of deregulated genes and their impact on cancer progression.
Pathway Analysis Results Will Be Reported To The Oncologists
Biological pathways are crucial in human cells. However, if they become deregulated, they can cause various consequences. Some of these pathways can be involved in metastasis. Here, we will show you the state of each of these pathways and provide you with the information needed about their role in cancer metastasis if they are deregulated.
Patients are staged based on their metastatic state and the molecular profile of genes that are important in metastasis and cancer progression
For cancer staging, mostly pathological methods are used, which can be very time-consuming. However, pathology images can sometimes detect cancer in its early stages, while its expression profile may indicate a higher grade. Our AI algorithm has been trained to accurately stage cancer based on its expression profiles. In addition to staging, the platform provides information about the genes and pathways involved in that particular stage.
You might also be interested in these features
Frequently Asked Questions
If you have any questions regarding the technical or operational aspects of our services that are not covered in the FAQ, please do not hesitate to contact us. Our support team will get in touch with you as soon as possible.
It will take only up to 72 hours to fully process the orders, and the results will be delivered to you. The brief scientific reports, as well as necessary supplemental files, will be available for you to download in your highly secure portal.
For most orders, it will take much less than 24 hours to be processed.
All orders must be placed through the Rayca Precision Portal, which is accessible via “portal.raycabio.com”. If you are not yet a verified user and do not have login credentials, kindly send a request for account activation. We will activate your account and send you the login credentials shortly.
Rayca Precision only offers services to healthcare professionals and medical practitioners. Furthermore, all of our services require the supervision of medical professionals and scientists to be applied to clinical settings and decision-making processes.
If you are a patient who is interested in having Rayca Precision solutions applied to your clinical decision-making process, please contact your healthcare provider or doctor and express your interest in Rayca Precision Solutions. They can then reach out to us directly.
Additionally, you can ask our team to check if Rayca Precision has any partnerships with your healthcare provider. In this case, we can assist you in establishing negotiations with your provider and ensuring that Rayca solutions will be applied to your treatment and clinical decision-making process under the supervision of your doctor.
Rayca Precision offers its solutions to any healthcare provider and research institutes, including hospitals, private practitioners, laboratories, sequencing centers, as well as cellular and molecular biology departments.
No! Rayca Precision specializes in running complex computations on patient data to extract high-level insights and make precise predictions on the patients’ clinical outcomes in order to design the most efficient treatment plan. All the required data comes from hospitals, clinical research centers, medical laboratories, and authorized affiliates of our partners who are the providers of the aforementioned patient data.
Rayca Precision accepts FASTQ files (Raw Sequencing Files) for any type of analysis requested by the user. Additionally, we also accept processed files such as count matrices.
Not at all! No preprocessing needs to be done on the data. Rayca requires the raw FASTQ files. All processing steps, including alignment, quality control, variant calling, variant annotation, and downstream analysis, will be performed in an automated workflow within Rayca’s precision data processing pipelines. Finally, the annotated data points will be ready for machine learning predictions.
Yes, Rayca Precision provides you with access to end-to-end encrypted storage to upload your sequencing data. This is a free service for all Rayca Precision clients and will not cost you any additional fees.
Yes! Rayca Precision grants you access to a secure portal to manage your Rayca account.
You are able to manage your orders, payments, invoices, and the results of your orders (analytical reports, files, scientific documents, etc.) all in one place using our highly secure web application portal.
To access the secure dashboard, you need to have an activated Rayca account and orders. If you have not yet activated your Rayca account, you can easily submit your account activation request. We will activate your account within 24 hours and send you the login credentials shortly thereafter.